FDA Adverse Event Malfunction Summary report: N

TREK CORONARY DILATATION CATHETER

MDR report key: 2853480 · Received November 30, 2012

Report

Report Number
2024168-2012-07613
Event Type
Malfunction
Date Received
November 30, 2012
Date of Event
October 25, 2012
Report Date
November 7, 2012
Manufacturer
AV-TEMECULA-CT
Product Code
LOX
PMA / PMN Number
K103110
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR EVALUATION. THE DEVICE WAS RETURNED WITH A TEAR AT THE GUIDE WIRE EXIT NOTCH; THE REPORTED LEAK WAS CONFIRMED. BASED ON ANALYSIS OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES FOR THIS LOT. THE RESULTS OF THE QUERY OF SIMILAR INCIDENTS IN THE COMPLAINT HANDLING DATABASE FOR THIS LOT DID NOT INDICATE A MANUFACTURING ISSUE. BASED ON THE INFORMATION REVIEWED, THERE IS NO EVIDENCE TO INDICATE THE PRESENCE OF A PRODUCT DEFICIENCY.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A PROCEDURE OF THE MODERATELY TORTUOUS, MODERATELY CALCIFIED, LEFT ANTERIOR DESCENDING (LAD) ARTERY, THE 3.0 X 15 MM TREK RX BALLOON DILATATION CATHETER (BDC) WAS ATTEMPTED TO BE INFLATED BUT A LEAK WAS NOTED. THE DEVICE WAS REMOVED WITHOUT INCIDENT. AFTER PRE-DILATATION, A XIENCE V STENT DELIVERY SYSTEM (SDS) WAS ATTEMPTED BUT COULD NOT CROSS THE LESION. A 2.5 X 12 MM XIENCE V SDS WAS USED SUCCESSFULLY IN THE PROCEDURE. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TREK CORONARY DILATATION CATHETER CORONARY DILATATION CATHETER LOX AV-TEMECULA-CT 20911G2

Patients

Seq Age Sex Outcome Treatment
1 67 YR